Medtech's dealmaking slump intensifies halfway through 2023
An analysis quantifies the moribund state of M&A in medtech, as well as the collapse in venture financings and IPOs.
Source: mmm-online.com
Stay updated with breaking news from Notwithstanding Thursday. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An analysis quantifies the moribund state of M&A in medtech, as well as the collapse in venture financings and IPOs.